TOP TEN perturbations for 1186_at (Homo sapiens)
Organism: Homo sapiens
Gene: 1186_at
Selected probe(set): 206159_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 1186_at (206159_at) across 6673 perturbations tested by GENEVESTIGATOR:
TC-71 / TC-32
Relative Expression (log2-ratio):5.798103Number of Samples:6 / 6
Experimental | TC-71 |
Human primary cancer cell line derived from the humerus of a patient with Ewing sarcoma. Synonyms:TC71; GM11654 Cellosaurus code: | |
Control | TC-32 |
Human primary cancer cell line derived from the unspecified origin of a patient with Ewing’s sarcoma. Synonyms:TC32 Cellosaurus code: |
expO stomach cancer study 1 (gastrointestinal stromal tumor; primary) / expO stomach cancer study 1 (Signet ring cell carcinoma; primary)
Relative Expression (log2-ratio):5.156665Number of Samples:2 / 2
Experimental | expO stomach cancer study 1 (gastrointestinal stromal tumor; primary) |
Primary tumor tissue samples obtained from the stomach of patients with gastrointestinal stromal tumor. | |
Control | expO stomach cancer study 1 (Signet ring cell carcinoma; primary) |
Primary tumor tissue samples obtained from the stomach of patients with Signet ring cell carcinoma. |
expO stomach cancer study 1 (gastrointestinal stromal tumor; primary) / expO stomach cancer study 1 (adenocarcinoma, NOS; primary)
Relative Expression (log2-ratio):5.110979Number of Samples:2 / 3
Experimental | expO stomach cancer study 1 (gastrointestinal stromal tumor; primary) |
Primary tumor tissue samples obtained from the stomach of patients with gastrointestinal stromal tumor. | |
Control | expO stomach cancer study 1 (adenocarcinoma, NOS; primary) |
Primary tumor tissue samples obtained from the stomach of patients with adenocarcinoma (NOS). |
brain tumor study 1 (glioblastoma) / brain tumor study 1 (ependymoma)
Relative Expression (log2-ratio):-4.299781Number of Samples:34 / 46
Experimental | brain tumor study 1 (glioblastoma) |
Primary tumor tissue sample from the brain of patients with glioblastoma multiformae. | |
Control | brain tumor study 1 (ependymoma) |
Primary tumor tissue sample from the brain of patients with ependymoma. |
brain tumor study 1 (medulloblastoma) / brain tumor study 1 (ependymoma)
Relative Expression (log2-ratio):-3.4716234Number of Samples:22 / 46
Experimental | brain tumor study 1 (medulloblastoma) |
Primary tumor tissue sample from the brain of patients with medulloblastoma. | |
Control | brain tumor study 1 (ependymoma) |
Primary tumor tissue sample from the brain of patients with ependymoma. |
lung adenocarcinoma study 6 (K-RAS mut) / adjacent lung tissue
Relative Expression (log2-ratio):-3.4514446Number of Samples:6 / 20
Experimental | lung adenocarcinoma study 6 (K-RAS mut) |
Primary tumor sample from patients with stage II adenocarcinoma carrying a K-RAS mutation. | |
Control | adjacent lung tissue |
Adjacent and histologically normal, non-tumorous lung tissue samples from patients with lung adenocarcinoma. |
lung adenocarcinoma study 3 / adjacent lung tissue
Relative Expression (log2-ratio):-3.397541Number of Samples:93 / 98
Experimental | lung adenocarcinoma study 3 |
Primary adenocarcinoma samples from the lung of patients with different stages and smoking status. | |
Control | adjacent lung tissue |
Adjacent, histologically normal and non-neoplastic tissue sample from the lung of patients with primary adenocarcinoma of the lung. Patients had different stages and smoking status. |
diphenylcyclopropenone study 1 (early) / placebo treated skin tissue
Relative Expression (log2-ratio):-3.2241287Number of Samples:10 / 11
Experimental | diphenylcyclopropenone study 1 (early) |
Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 3 days. ATC code:--- | |
Control | placebo treated skin tissue |
Skin biopsy samples of healthy volunteers exposed to placebo for 3 days. |
lung adenocarcinoma study 6 (EGFR mut) / adjacent lung tissue
Relative Expression (log2-ratio):-3.2197313Number of Samples:24 / 20
Experimental | lung adenocarcinoma study 6 (EGFR mut) |
Primary tumor sample from patients with stage II adenocarcinoma carrying an EGFR mutation. | |
Control | adjacent lung tissue |
Adjacent and histologically normal, non-tumorous lung tissue samples from patients with lung adenocarcinoma. |
diphenylcyclopropenone study 1 (late) / diphenylcyclopropenone study 1 (early)
Relative Expression (log2-ratio):3.1541605Number of Samples:6 / 10
Experimental | diphenylcyclopropenone study 1 (late) |
Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 4 to 8 months. ATC code:--- | |
Control | diphenylcyclopropenone study 1 (early) |
Skin biopsy samples of healthy volunteers exposed to diphenylcyclopropenone (diphencyprone; DPCP) for 3 days. ATC code:--- |